Mentions
Extended reach
Total likes
Video views
AI synopsis
Many discussions highlight the findings of the AQUATIC trial, with specific mentions of increased risks of cardiovascular events and major bleeding associated with aspirin usage in patients already on oral anticoagulation. Phrases like 'not a good idea' and 'higher morbidity and mortality' illustrate the alarming tone surrounding the article's implications, showcasing how the choice of words effectively conveys the significance and urgency of reassessing treatment protocols.
A significant number of discussions express agreement with the findings that adding aspirin increases risks in high-risk patients.
There is a pronounced interest in the implications of this trial, as many participants reference specific results and express curiosity about the ramifications.
While many posts show excitement, the overall engagement remains mostly on the surface with limited deep discussions or critiques.
The majority view the study as having a substantial impact on treatment practices and guidelines for patients with chronic coronary syndrome.
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary syndrome at high atherothrombotic risk who were receiving an oral anticoagulant, the addition of aspirin led to a higher risk of cardiovascular death, https://t.co/lXMT7FVYL4
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary syndrome at high atherothrombotic risk who were receiving an oral anticoagulant, the addition of aspirin led to a higher risk of cardiovascular death, https://t.co/p7GBZmtTq0
Less seems to be more for antithrombotics! Two RCTs converge on oral anticoagulation monotherapy over anticoagulants+antiplatelets https://t.co/KwLJuDCDDY https://t.co/bccVUun0Tt
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation | New England Journal of Medicine https://t.co/F3adcpA47n
Aspirin use in high-risk coronary syndrome patients increases cardiovascular events and major bleeding, leading to early trial cessation. by Lemesle G, Didier R (...) Cayla G et 17 al. in N Engl J Med #MedSky
In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular events, major bleeding, and death from any cause than anticoagulation alone. Full AQUATIC trial results and Research Summary: nej.md/45AU4Wp #MedSky #CardioSky
This week, John Mandrola MD discusses the safety issues of combining aspirin with long-term anticoagulation in patients with chronic coronary syndrome. The study showed increased adverse outcomes, including higher…
This week, John Mandrola MD discusses key findings from the Danish Cardiovascular Screening Trial. The trial, involving over 46,000 men aged 65-74, showed no significant reduction in mortality but indicated lower rates…
Prof. Bikdeli and Prof. Didier discuss the HIPRO study on extended treatment of provoked venous thromboembolism, presented at the 2025 European Society of Cardiology meeting. The study compares rivaroxaban monotherapy…
Prof Romain Didier and Prof Behnood Bikdeli discuss the AQUATIC study on antiplatelet drugs in patients with chronic coronary syndrome receiving oral anticoagulation, highlighting recent findings on therapy optimization…
AQUATIC trial: In Pts with chronic coronary syndrome with PCI more than 6 months prior and on background OAC, ASA 100 mg/d ⬆️MACE vs. placebo (ARI 4.8% at 2.2 years). Mostly driven by ⬆️all-cause death (ARI 5%). Also more major bleed with ASA (ARI 6.8%). https://t.co/tgRDWUiFqU https://t.co/wbx5JniUbn
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation | New England Journal of Medicine https://t.co/KuRR2XS3DK
Co się stanie jak pacjentowi na ASA (lek przeciw agregacji płytek krwi) damy antykoagulant (lek hamujący osoczowe krzepnięcie)? Wbrew pozorom wzrośnie ryzyko zakrzepów! Badanie Aquatic pokazuje że chłopski rozum nie działa w medycynie. Vive l’empirisme! https://t.co/37aDFxU9GN
Aspirin Increases Risks of Cardiovascular Death and Major Bleeding in High-Risk Chronic Coronary Patients on Anticoagulation. by Lemesle G, Didier R (...) Cayla G et 17 al. in N Engl J Med #MedSky
Aspirin Increases Risks of Cardiovascular Death and Major Bleeding in High-Risk Chronic Coronary Patients on Anticoagulation. by Lemesle G, Didier R (...) Cayla G et 17 al. in N Engl J Med https://t.co/p49MWf0GhF #MedX #MedResearch
RT @NEJM: New in the October 23, 2025, issue of NEJM: Hypertonic Saline or Carbocisteine in Bronchiectasis (CLEAR trial) https://t.co/Fl…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @drjohnm: The AQUATIC trial may be the most definitive trial of #ESCCOngress The common combo of ASA and OAC for pts with CAD/stent an…
RT @DrZebra1: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation | New England Journal of Medicine https://t…
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation | New England Journal of Medicine https://t.co/F3adcpA47n
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @EddieRDMD: NEJM: AQUATIC trial, In chronic coronary syndrome patients on oral anticoagulants, adding aspirin increased CV events, major…
RT @Sefap_FAP:
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
I hope I will finally stop seeing so much aspirin on top of OAC. Before this study it already seemed a bad idea but now more evidence Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation | New England Journal of Medicine https://t.co/sXhkUhNXL8
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @FarmaMadridAP: (NEJM) En pacientes con síndomre coronario crónico anticuagulados la adicción de aspirina conllevó un mayor riesgo de m…
RT @FarmaMadridAP: (NEJM) En pacientes con síndomre coronario crónico anticuagulados la adicción de aspirina conllevó un mayor riesgo de m…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @FarmaMadridAP: (NEJM) En pacientes con síndomre coronario crónico anticuagulados la adicción de aspirina conllevó un mayor riesgo de m…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @FarmaMadridAP: (NEJM) En pacientes con síndomre coronario crónico anticuagulados la adicción de aspirina conllevó un mayor riesgo de m…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
NEJM: AQUATIC trial, In chronic coronary syndrome patients on oral anticoagulants, adding aspirin increased CV events, major bleeding, & all-cause death vs. anticoagulation alone. Full results & summary: #Cardiology #ClinicalTrial https://t.co/gspTf9tGtm @SeeFisch https://t.co/NJtVkk5sT8
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @FarmaMadridAP: (NEJM) En pacientes con síndomre coronario crónico anticuagulados la adicción de aspirina conllevó un mayor riesgo de m…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @Sefap_FAP:
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @yumino_medical: 【DrゆみのWeekly Journal Scan】 ＊DOAC内服の慢性冠症候群患者におけるアスピリンの上乗せ効果 from NEJM＊ https://t.co/VbJ4ScgPyQ…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @FarmaMadridAP: (NEJM) En pacientes con síndomre coronario crónico anticuagulados la adicción de aspirina conllevó un mayor riesgo de m…
RT @FarmaMadridAP: (NEJM) En pacientes con síndomre coronario crónico anticuagulados la adicción de aspirina conllevó un mayor riesgo de m…
(NEJM) En pacientes con síndomre coronario crónico anticuagulados la adicción de aspirina conllevó un mayor riesgo de muerte CV, IAM, ACV...vs placebo, así como un mayor riesgo de muerte hemorragia https://t.co/yDnxO9ldmn
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
【DrゆみのWeekly Journal Scan】 ＊DOAC内服の慢性冠症候群患者におけるアスピリンの上乗せ効果 from NEJM＊ https://t.co/VbJ4ScgPyQ
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary syndrome at high atherothrombotic risk who were receiving an oral anticoagulant, the addition of aspirin led to a higher risk of cardiovascular death, https://t.co/p7GBZmtTq0
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular event…
In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular events, major bleeding, and death from any cause than anticoagulation alone. Full AQUATIC trial results and Research Summary: nej.md/45AU4Wp #MedSky #CardioSky
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
Be careful with Aspirin in Patients with chronic coronary syndrome receiving oral anticoagulation. Higher morbidity and mortality without benefit compared to placebo! @NEJM @NEJMEvidence https://t.co/xFKEyxh5Dv https://t.co/mHGiKEtR0G
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation @NEJM https://t.co/50f5fznWiL @DrAsifQasim @AskDrShashank Adding aspirin to a DOAC increases risk of bleeding https://t.co/a9HMrAG917
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @preopconsult: Pts with CCD did worse with the addition of ASA to oral anticoagulation-don’t do it. Similar to guideline recs for pts wi…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
Do not add #Aspirin to #oral_anticoagulant in #Chronic_coronary_syndrome @NEJM #AQUATIC trial, least we significantly increase the combined of: CV death, MI, CVA, systemic embolism, coronary revas., or acute limb ischaemia @SheffieldHosp #cardiotwitter https://t.co/b8BNdEVsuI
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation | New England Journal of Medicine https://t.co/l7fK0ZBGOk
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @OleksandrKashu2: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation This article was published on 31 Aug…
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation This article was published on 31 August 2025, at https://t.co/O4U4PIp34O. https://t.co/CQoAwCiUhM https://t.co/iWzNclp5Bu
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation www.nejm.org/doi/pdf/10.1...
Aspirin in Patients with Chronic Coronary Syndrome Receiving Anticoagulants | New England Journal of Medicine www.nejm.org/do/10.1056/N...
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @DrPascalMeier: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) increases major advers…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @crisguijarro1: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation | New England Journal of Medicine. the…
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation | New England Journal of Medicine. the addition of aspirin led to a higher risk of cardiovascular death, myocardial infarction, stroke, systemic embolism, coronary revascula. https://t.co/iJfn8UT70F
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) increases major adverse cardiac events, and of bleeding risk. https://t.co/HFYLyTX3j1 @NEJM https://t.co/o7fAVORbqQ
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation | New England Journal of Medicine https://t.co/SpdfAXQ0zu
RT @drbennisahmed: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary…
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation Among patients with chronic coronary syndrome at high atherothrombotic risk who were receiving an oral anticoagulant, the addition of aspirin led to a higher risk of cardiovascular death, https://t.co/lXMT7FVYL4
RT @NEJM: Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) https://t.co/…
New England Journal of Medicine, Volume 393, Issue 16, Page 1578-1588, October 23, 2025. https://www.nejm.org/doi/full/10.1056/NEJMoa2507532?af=R&rss=currentIssue
RT @xabierurra: Less seems to be more for antithrombotics! Two RCTs converge on oral anticoagulation monotherapy over anticoagulants+antipl…
Less seems to be more for antithrombotics! Two RCTs converge on oral anticoagulation monotherapy over anticoagulants+antiplatelets https://t.co/KwLJuDCDDY https://t.co/bccVUun0Tt
“Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.” Publié ce jour dans le @nejm.org #MedSky #CardioSky www.nejm.org/doi/full/10....
Aspirina en pacientes con síndrome coronario crónico que reciben anticoagulación oral https://t.co/aXLmJSa7iC PMID 40888725
https://t.co/e0coUTWCLI あとでよむ
For stable CAD patients on an OAC, think twice before adding aspirin. A new trial shows this combo increased ischemic events, all-cause mortality, and major bleeding vs. OAC alone. The study was stopped early due to clear harm. https://t.co/XqJU7iWGTw
RT @pinacol: 【RCT】ステント留置を受けたアテローム血栓リスクが高く長期間の抗血栓薬を服用している慢性冠症候群患者へのアスピリンは、プラセボと比較して、心血管死亡、心筋梗塞、脳卒中、全身性塞栓症、冠血行再建、急性肢虚血の複合転帰を増加させた。大出血も増加させた。…
L'aspirine en plus de l'anticoagulation curative à distance d'un stent coronarien ? Pas forcément une bonne idée ! ⬇ https://t.co/saGwBqAGFM
Aspirin use in high-risk coronary syndrome patients increases cardiovascular events and major bleeding, leading to early trial cessation. by Lemesle G, Didier R (...) Cayla G et 17 al. in N Engl J Med #MedSky
Aspirin use in high-risk coronary syndrome patients increases cardiovascular events and major bleeding, leading to early trial cessation. by Lemesle G, Didier R (...) Cayla G et 17 al. in N Engl J Med https://t.co/p49MWf0GhF #MedX #MedResearch
【RCT】ステント留置を受けたアテローム血栓リスクが高く長期間の抗血栓薬を服用している慢性冠症候群患者へのアスピリンは、プラセボと比較して、心血管死亡、心筋梗塞、脳卒中、全身性塞栓症、冠血行再建、急性肢虚血の複合転帰を増加させた。大出血も増加させた。 #ペ読 https://t.co/3ulT89Z7EG
"Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation." Présenté ce jour a #ESCCongress et publié dans le @nejm.org. #MedSky #CardioSky #ESC2025 www.nejm.org/doi/full/10....
AM
XU
IZ
DL
A
J
SR
GK
Dا
PN
C
LV
E
FR
TB
AG
D
JJ
HH
SL
JM
AL
DL
IC
A
EL
MB
NG
AC
CF
MV
LB
AB
L
I
DY
S
Z
ME
FM
MM
SH
OC
D
DV
PC
C
SC
NH
DS
M
DR
K
JM
L
A
SA
W
M
FG
DJ
弓Y
ZF
YD
TC
JN
FA
A
W
S
医
NS
DA
BF
MA
บ
DJ
R
TM
DK
RD
NM
KV
YW
HA
OM
WM
DV
ES
ZA
N
AA
DF
DA
WC
XJ
AK
?
MS
DS
DA
GP
LU
R
JT
DB
MS
MA
SF
F
C
AA
J
đH
TH
LD
T
DG
MP
KT
GA
S
NP
JM
PM
D
ふ
AM
RB
V
FM
MR
MM
E
EJ
MM
VD
TF
SM
AA
FZ
FL
H佐
MY
LH
RC
GF
VV
DP
HV
HC
EA
G
AA
PB
DB
U
C
PM
FW
N
JM
CH
Wا
SP
D
FG
KF
EC
ME
BC
JQ
BR
AH
LA
DL
OH
RM
AJ
CF
SM
AG
P